Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05564273

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Metabolic Conditions

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Viome · Industry
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.

Detailed description

Participants who meet the eligibility criteria are randomized into any of the three arms including: the placebo arm, VIOME's condition-based supplements (VCS) arm or the VIOME Precision Nutrition Program (VPNP) arm. Placebo, Viome-designed condition-based supplements and Viome's Precision Nutrition Program include supplements and/or dietary recommendations towards improving the symptoms associated with metabolic wellness. The trial will last approximately 4 months for each participant.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTVIOME Precision Nutrition ProgramPrecision supplement based on the participants microbiome sample results. Participants in this arm may receive supplements, diet recommendations, and app coaching.
DIETARY_SUPPLEMENTVIOME-designed condition-based supplementsPre-formulated supplements based on overall health conditions. Participants in this arm may receive supplements, diet recommendations, and app coaching.

Timeline

Start date
2023-10-13
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2022-10-03
Last updated
2025-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05564273. Inclusion in this directory is not an endorsement.